Rocket Pharmaceuticals- Warrants (02/09/2026) Total Liabilities

The latest total liabilities for RCKTW is $93M as of September 2026. That compares with $54M in the prior-year period — up 70.7% year over year. Investors often review this figure alongside Rocket Pharmaceuticals- Warrants (02/09/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, RCKTW's total liabilities moved from $54M to $93M — a 70.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Rocket Pharmaceuticals- Warrants (02/09/2026)'s operating scale or balance-sheet position.

A total liabilities figure of $93M for RCKTW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RCKTW's total liabilities ($93M), review year-over-year change from $54M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Rocket Pharmaceuticals- Warrants (02/09/2026)'s total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.